FundedIQ
Biotechnology

Encision: Funding, Investors & Team (Oct 2026)

Encision, a US-based medical device company, creates and sells patented surgical instruments, specifically Active Electrode Monitoring (AEM) instruments, to improve electrosurgery and lower the risk of patient harm in minimally invasive procedures. Their product range includes articulating instruments, fixed-tip electrodes, and handles designed for advanced laparoscopic surgeries. They also offer an AEM monitor product line to be used alongside their instruments. Encision primarily sells its products to hospitals through their network of sales representatives. The company was established in 1991 and is headquartered in Boulder, Colorado.

encision.com LinkedIn Boulder, United States 51-100 employees
Biotechnology Developer Platform Health Care Manufacturing Medical Device
Total raised
$500k
Rounds
1
Latest
Undisclosed round
Aug 2025

Encision has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in Aug 2025.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Encision Company Profile and Key Stats

Total funding raised
$500k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$500k in Aug 2025
Employees
51-100
reported band
Headquarters
Boulder, United States

Latest funding round on record: Aug 2025.

Encision Funding Rounds

Date
Round
Amount
Undisclosed round
$500k

Encision Founders and Leadership Team

Name
Role
Contact
Roger C Odell
Founder
—

No contact details are on record for this team yet.

Encision Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Encision's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Encision in Biotechnology and Boulder

Companies Similar to Encision

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Encision Funding FAQs

What does Encision do?

Encision, a US-based medical device company, creates and sells patented surgical instruments, specifically Active Electrode Monitoring (AEM) instruments, to improve electrosurgery and lower the risk of patient harm in minimally invasive procedures. Their product range includes articulating instruments, fixed-tip electrodes, and handles designed for advanced laparoscopic surgeries. They also offer an AEM monitor product line to be used alongside their instruments. Encision primarily sells its products to hospitals through their network of sales representatives. The company was established in 1991 and is headquartered in Boulder, Colorado.

How much funding has Encision raised?

Encision has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in Aug 2025.

When did Encision last raise funding?

Encision's most recent funding round on record is an undisclosed round of $500k, announced in Aug 2025.

Who founded Encision?

FundedIQ lists Roger C Odell (Founder) at Encision.

Where is Encision headquartered?

Encision is based in Boulder, Colorado, United States.

How many employees does Encision have?

Encision is in the 51-100 employee band.

How does Encision's funding compare to other Biotechnology startups?

Encision's latest round of $500k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Encision Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Encision is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.